National Health Investors, Inc. (NYSE: NHI) Update on Short-Term Interest Rates

0

National Health Investors, Inc. (NYSE: NHI) enjoyed a significant increase in short-term interest during the month of November. As of November 15, there was short interest totaling 1,350,000 shares, an increase of 18.4% from the total of 1,140,000 shares as of October 31. Based on an average daily volume of 318,300 shares, the short-term interest rate is currently 4.2 days. About 3.1% of the company’s shares are sold short.

Separately, director Robert T. Webb bought 2,000 shares of National Health Investors in a trade on Thursday, September 30. The stock was purchased at an average price of $ 53.86 per share, for a total value of $ 107,720.00. The acquisition has been disclosed in a legal file with the Securities & Exchange Commission, which is available through this link. In addition, director Robert T. Webb bought 1,000 shares of National Health Investors in a trade on Monday, November 29. The stock was purchased at an average cost of $ 52.86 per share, for a total value of $ 52,860.00. Disclosure of this purchase can be found here. In the past three months, insiders have purchased 8,000 shares of the company valued at $ 437,030. Insiders own 6.55% of the company’s shares.

Several institutional investors and hedge funds have recently increased or reduced their holdings in the stock. Bank of New York Mellon Corp increased its position in National Health Investors shares by 1.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 896,308 real estate investment trust shares valued at $ 47,952,000 after purchasing an additional 11,999 shares in the last quarter. Wealth Quarterback LLC increased its stake in National Health Investors by 427.1% during the 3rd quarter. Wealth Quarterback LLC now owns 4,544 real estate investment trust shares worth $ 44,000 after purchasing an additional 3,682 shares in the last quarter. Jane Street Group LLC purchased a new position in National Health Investors during the third quarter valued at approximately $ 966,000. Squarepoint Ops LLC purchased a new position in National Health Investors during the third quarter valued at approximately $ 214,000. Finally, Two Sigma Investments LP purchased a new position in National Health Investors during the 3rd quarter for a value of approximately $ 1,446,000. Institutional investors and hedge funds hold 63.79% of the company’s shares.

(A d)

This guide will help you assess and analyze your trading plan to create a personalized options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.

NYSE: NHI traded up $ 0.22 during trading hours on Friday, reaching $ 53.46. 332,094 shares of the security were traded, for an average volume of 311,482. The company’s 50-day moving average is $ 55.04 and its two-hundred-day moving average is $ 61.63. The company has a rapid ratio of 16.11, a current ratio of 20.73 and a debt ratio of 0.83. The company has a market cap of $ 2.45 billion, a P / E ratio of 17.08 and a beta of 0.91. National Health Investors has a year-over-year low of $ 50.88 and a year-over-year high of $ 78.56.

National Health Investors (NYSE: NHI) last released its quarterly results on Monday, November 8. The REIT reported earnings of $ 0.67 per share for the quarter, missing the Zacks’ consensus estimate of $ 1.18 of ($ 0.51). National Health Investors had a net margin of 45.92% and a return on equity of 9.20%. The company posted revenue of $ 73.83 million in the quarter, compared to analysts’ estimates of $ 74.21 million. During the same period last year, the company earned $ 1.42 per share. The company’s revenue for the quarter was down 12.4% from the same quarter last year. On average, equity research analysts expect National Health Investors to post 4.7 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 31. Investors of record on Friday, December 31 will receive a dividend of $ 0.90. This represents a dividend of $ 3.60 on an annualized basis and a dividend yield of 6.73%. The ex-dividend date is Thursday, December 30. National Health Investors’ dividend payout ratio is currently 115.02%.

INSA has been the subject of several research reports. Truist Securities lowered its price target on National Health Investors from $ 71.00 to $ 64.00 and set a “custody” rating for the stock in a research note on Thursday, September 23. Zacks Investment Research downgraded National Health Investors from a “hold” rating to a “sell” rating in a Tuesday, November 2 research note. Truist lowered its price target on National Health Investors from $ 71.00 to $ 64.00 and set a “conservation” rating for the stock in a research note on Thursday, September 23. TheStreet downgraded National Health Investors from a “b-” rating to a “c +” rating in a Friday, October 8 research note. Finally, Capital One Financial has raised National Health Investors from a rating “on par” to an “overweight” rating in a report released on Tuesday, November 9. Two research analysts rated the stock with a sell rating, five assigned a conservation rating, and one assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $ 68.29.

About National Health Investors

National Health Investors, Inc. is a real estate investment trust, engaged in sale and leaseback, joint venture, mortgage and mezzanine financing of senior housing and medical investments. Its portfolio includes leases, mortgages and other investments in independent residences, assisted living facilities, paying communities, senior campuses, skilled nursing facilities, specialty hospitals and medical office buildings.

Read more: How does equity income fit into an investment strategy?

This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]

Should You Invest $ 1,000 In National Health Investors Now?

Before you consider National Health Investors, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold of… and National Health Investors was not on the list.

While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Share.

Comments are closed.